No excess mortality after prostate biopsy: Results from the European Randomized Study of Screening for Prostate Cancer

BJU International

Volumn 107, Issue 12, 2011, Pages 1912-1917

  Carlsson, Sigrid V ^a,f   Holmberg, Erik ^a   Moss, Sue M ^b   Roobol, Monique J ^e   Schröder, Fritz H ^e   Tammela, Teuvo L J ^c   Aus, Gunnar ^a   Auvinen, Anssi P ^d   Hugosson, Jonas ^a  

^a SAHLGRENSKA ACADEMY AT UNIVERSITY OF GOTHENBURG   (Sweden)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

^e ERASMUS MEDICAL CENTER   (Netherlands)

^f SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

mortality; prostate biopsy; prostate cancer; PSA; screening

Indexed keywords

CIPROFLOXACIN; GENTAMICIN; QUINOLONE DERIVATIVE; SULFONAMIDE;

ADULT; AGED; ANAEROBIC INFECTION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; FINLAND; HEMOSPERMIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NEPHROSIS; NETHERLANDS; OUTCOME ASSESSMENT; PERITONITIS; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SWEDEN; TREATMENT RESPONSE; UROSEPSIS;

AGED; BIOPSY, NEEDLE; EARLY DETECTION OF CANCER; EPIDEMIOLOGIC METHODS; FINLAND; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; NETHERLANDS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; SEPSIS; SWEDEN;

EID: 79957869220     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2010.09712.x     Document Type: Article

References (29)

1. Schroder FH, Hugosson J, Roobol MJ, et al,. Screening and prostate-cancer mortality in a randomized European study. N Engl J Med 2009; 360: 1320-8
2. Mäkinen T, Auvinen A, Hakama M, Stenman UH, Tammela TL,. Acceptability and complications of prostate biopsy in population-based PSA screening versus routine clinical practice: a prospective, controlled study. Urology 2002; 60: 846-50 (Pubitemid 35300352)
3. Clements R, Aideyan OU, Griffiths GJ, Peeling WB,. Side effects and patient acceptability of transrectal biopsy of the prostate. Clin Radiol 1993; 47: 125-6 (Pubitemid 23077828)
4. Raaijmakers R, Kirkels WJ, Roobol MJ, Wildhagen MF, Schrder FH,. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology 2002; 60: 826-30 (Pubitemid 35300348)
5. Gonen M, Resim S,. Simplified treatment of massive rectal bleeding following prostate needle biopsy. Int J Urol 2004; 11: 570-2 (Pubitemid 39070751)
6. Brullet E, Guevara MC, Campo R, et al,. Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Endoscopy 2000; 32: 792-5
7. Ustundag Y, Yesilli C, Aydemir S, Savranlar A, Yazicioglu K,. A life-threatening hematochesia after transrectal ultrasound-guided prostate needle biopsy in a prostate cancer case presenting with lymphedema. Int Urol Nephrol 2004; 36: 397-400
8. Strate LL, O'Leary MP, Carr-Locke DL,. Endoscopic treatment of massive rectal bleeding following prostate needle biopsy. Endoscopy 2001; 33: 981-4 (Pubitemid 33034737)
9. Braun KP, May M, Helke C, Hoschke B, Ernst H,. Endoscopic therapy of a massive rectal bleeding after prostate biopsy. Int Urol Nephrol 2007; 39: 1125-9 (Pubitemid 350193605)
10. Katsinelos P, Kountouras J, Dimitriadis G, et al,. Endoclipping treatment of life-threatening rectal bleeding after prostate biopsy. World J Gastroenterol 2009; 15: 1130-3
11. Pacios E, Esteban JM, Breton ML, Alonso MA, Sicilia-Urban JJ, Fidalgo MP,. Endoscopic treatment of massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Scand J Urol Nephrol 2007; 41: 561-2 (Pubitemid 350207541)
12. Dunn IB, Underwood MJ, Kirk D,. Profuse rectal bleeding after prostatic biopsy: a life-threatening complication dealt with simply. BJU Int 2000; 86: 910
13. Petroski RA, Griewe GL, Schenkman NS,. Delayed life-threatening hemorrhage after transrectal prostate needle biopsy. Prostate Cancer Prostatic Dis 2003; 6: 190-2 (Pubitemid 36798391)
14. Dauleh MI, Byrne DJ,. Severe bleeding following transrectal Tru-cut prostatic biopsy. Scand J Urol Nephrol 1996; 30: 153-4 (Pubitemid 26165039)
15. Breslin JA, Turner BI, Faber RB, Rhamy RK,. Anaerobic infection as a consequence of transrectal prostatic biopsy. J Urol 1978; 120: 502-3 (Pubitemid 9031124)
16. Brewster SF, Rooney N, Kabala J, Feneley RC,. Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumour. Br J Urol 1993; 72: 977-8 (Pubitemid 24053532)
17. Borer A, Gilad J, Sikuler E, Riesenberg K, Schlaeffer F, Buskila D,. Fatal Clostridium sordellii ischio-rectal abscess with septicaemia complicating ultrasound-guided transrectal prostate biopsy. J Infect 1999; 38: 128-9 (Pubitemid 29229641)
18. da Silva E, Pereiro Alvarez B, Garimaldi Perez S, et al,. [Peritonitis following transrectal biopsy of the prostate]. Arch Esp Urol 1999; 52: 167-8
19. Davison P, Malament M,. Urinary contamination as a result of transrectal biopsy of the prostate. J Urol 1971; 105: 545-6
20. Esposti PL, Elman A, Norlen H,. Complications of transrectal aspiration biopsy of the prostate. Scand J Urol Nephrol 1975; 9: 208-13
21. Hasegawa T, Shimomura T, Yamada H, et al,. [Fatal septic shock caused by transrectal needle biopsy of the prostate; a case report]. Kansenshogaku Zasshi 2002; 76: 893-7
22. Emmett JL, Barber KWJ,. Transrectal biopsy to detect prostatic carcinoma: a review and report of 203 cases. J Urol 1962; 87: 460-74
23. Kakehi Y, Naito S, Japanese Urological A,. Complication rates of ultrasound-guided prostate biopsy: a nation-wide survey in Japan. Int J Urol 2008; 15: 319-21 (Pubitemid 351490162)
24. Gallina A, Suardi N, Montorsi F, et al,. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men. Int J Cancer 2008; 123: 647-52 (Pubitemid 351898424)
25. Schroder FH, Denis LJ, Roobol M, et al,. The story of the European Randomized Study of Screening for Prostate Cancer. BJU Int 2003; 92 (Suppl. 2): 1-13 (Pubitemid 38091131)
26. ERSPC-Website. Available at:. Accessed September 2009
27. Rietbergen JB, Kruger AE, Kranse R, Schroder FH,. Complications of transrectal ultrasound-guided systematic sextant biopsies of the prostate: evaluation of complication rates and risk factors within a population-based screening program. Urology 1997; 49: 875-80 (Pubitemid 27246956)
28. Fang F, Keating NL, Mucci LA, et al,. Immediate risk of suicide and cardiovascular death after a prostate cancer diagnosis: cohort study in the United States. J Natl Cancer Inst 2010; 102: 307-14
29. Nam RK, Saskin R, Lee Y, et al,. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol 2010; 183: 963-8